Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review

The global panic of the novel coronavirus disease 2019 (COVID-19) triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an urgent requirement for effective therapy. COVID-19 infection, especially in severely ill patients, is likely to be associated with immune dysr...

Descripción completa

Detalles Bibliográficos
Autores principales: Razmi, Mahdieh, Hashemi, Farideh, Gheytanchi, Elmira, Dehghan Manshadi, Masoumeh, Ghods, Roya, Madjd, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456184/
https://www.ncbi.nlm.nih.gov/pubmed/32896750
http://dx.doi.org/10.1016/j.intimp.2020.106942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456184/
https://www.ncbi.nlm.nih.gov/pubmed/32896750
http://dx.doi.org/10.1016/j.intimp.2020.106942

Ejemplares similares